IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,569 | +77.1% | 889,672 | +95.6% | 0.01% | +66.7% |
| Q2 2023 | $4,839 | +38.2% | 454,798 | +36.6% | 0.00% | +50.0% |
| Q1 2023 | $3,502 | -40.7% | 333,013 | -30.1% | 0.00% | -33.3% |
| Q4 2022 | $5,901 | -99.9% | 476,199 | -17.1% | 0.00% | -50.0% |
| Q3 2022 | $5,951,000 | +328.4% | 574,495 | +376.7% | 0.01% | +500.0% |
| Q2 2022 | $1,389,000 | -75.8% | 120,507 | -73.6% | 0.00% | -75.0% |
| Q1 2022 | $5,737,000 | +10.8% | 456,098 | +2.6% | 0.00% | +300.0% |
| Q4 2021 | $5,180,000 | +83.9% | 444,408 | +106.0% | 0.00% | 0.0% |
| Q3 2021 | $2,816,000 | -2.9% | 215,716 | -4.3% | 0.00% | 0.0% |
| Q2 2021 | $2,899,000 | -41.4% | 225,355 | -49.1% | 0.00% | -66.7% |
| Q1 2021 | $4,946,000 | +15.1% | 442,401 | +17.3% | 0.00% | +50.0% |
| Q4 2020 | $4,297,000 | -2.8% | 377,228 | -23.2% | 0.00% | -33.3% |
| Q3 2020 | $4,421,000 | +54.6% | 491,410 | +77.4% | 0.00% | +50.0% |
| Q2 2020 | $2,860,000 | +23.0% | 277,033 | +20.2% | 0.00% | 0.0% |
| Q1 2020 | $2,325,000 | +4.1% | 230,468 | +37.3% | 0.00% | +100.0% |
| Q4 2019 | $2,234,000 | +168.2% | 167,816 | +72.7% | 0.00% | 0.0% |
| Q3 2019 | $833,000 | -48.9% | 97,149 | -34.8% | 0.00% | 0.0% |
| Q2 2019 | $1,631,000 | -50.4% | 149,028 | -38.6% | 0.00% | -50.0% |
| Q1 2019 | $3,285,000 | +36.8% | 242,800 | +4.8% | 0.00% | +100.0% |
| Q4 2018 | $2,401,000 | +10.3% | 231,759 | +96.5% | 0.00% | -50.0% |
| Q3 2018 | $2,176,000 | +921.6% | 117,938 | +957.8% | 0.00% | – |
| Q2 2018 | $213,000 | -58.3% | 11,149 | -66.4% | 0.00% | – |
| Q1 2018 | $511,000 | -93.8% | 33,180 | -94.0% | 0.00% | -100.0% |
| Q4 2017 | $8,307,000 | +8553.1% | 554,173 | +8984.8% | 0.01% | – |
| Q3 2017 | $96,000 | +300.0% | 6,100 | +390.0% | 0.00% | – |
| Q2 2017 | $24,000 | -66.2% | 1,245 | -70.0% | 0.00% | – |
| Q1 2017 | $71,000 | -66.7% | 4,150 | -70.2% | 0.00% | – |
| Q4 2016 | $213,000 | -6.2% | 13,915 | -3.1% | 0.00% | – |
| Q3 2016 | $227,000 | -90.4% | 14,353 | -92.1% | 0.00% | -100.0% |
| Q2 2016 | $2,366,000 | -8.5% | 181,020 | -30.0% | 0.00% | -40.0% |
| Q1 2016 | $2,587,000 | +527.9% | 258,656 | +590.9% | 0.01% | +400.0% |
| Q4 2015 | $412,000 | -54.3% | 37,435 | -58.5% | 0.00% | 0.0% |
| Q3 2015 | $902,000 | +10.9% | 90,115 | +32.9% | 0.00% | 0.0% |
| Q2 2015 | $813,000 | +375.4% | 67,811 | +535.8% | 0.00% | – |
| Q1 2015 | $171,000 | -20.1% | 10,665 | -24.9% | 0.00% | – |
| Q4 2014 | $214,000 | -1.4% | 14,206 | -21.6% | 0.00% | – |
| Q3 2014 | $217,000 | -95.5% | 18,127 | -94.4% | 0.00% | -100.0% |
| Q2 2014 | $4,858,000 | +1820.2% | 323,741 | +1431.5% | 0.01% | – |
| Q1 2014 | $253,000 | +91.7% | 21,139 | +77.7% | 0.00% | – |
| Q4 2013 | $132,000 | -70.5% | 11,894 | -70.8% | 0.00% | -100.0% |
| Q3 2013 | $447,000 | -69.5% | 40,718 | -72.4% | 0.00% | -50.0% |
| Q2 2013 | $1,467,000 | – | 147,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |